IOM Report: Clinical Trials in Kids Working

An Institute of Medicine report says laws motivating drug makers to test medicines in children have found information that has helped pediatric physicians give better care.

The report cautions that studies in newborns and long-term drug usage as kids get older continue to be limited, according to a report by MedPage Today.

Congress passes two federal laws, the Best Pharaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA), to provide incentives and mandate pediatric studies in certain situations. Both laws are up for reauthorization this year, according to the story.

The IOM report found both laws had a positive impact on guiding clinical care for kids.

Return to listing